STRS Ohio’s Maravai LifeSciences MRVI Stock Holding History

STRS Ohio’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$847K	Sell	135,800 -28,500	-17%	-$123K	﹤0.01%	808
2026 Q1	$465K	Hold	164,300	–	–	﹤0.01%	1122
2025 Q4	$534K	Sell	164,300 -44,500	-21%	-$150K	﹤0.01%	1044
2025 Q3	$599K	Hold	208,800	–	–	﹤0.01%	936
2025 Q2	$503K	Buy	208,800 +14,800	+8%	+$31.1K	﹤0.01%	1294
2025 Q1	$429K	Buy	194,000 +84,200	+77%	+$333K	﹤0.01%	1271
2024 Q4	$598K	Buy	109,800 +29,900	+37%	+$192K	﹤0.01%	1072
2024 Q3	$664K	Sell	79,900 -5,900	-7%	-$51K	﹤0.01%	1084
2024 Q2	$614K	Buy	+85,800	New	+$741K	﹤0.01%	1087
2022 Q1	–	Sell	-180,586	Closed	-$7.57M	–	2213
2021 Q4	$7.57M	Buy	180,586 +29,586	+20%	+$1.2M	0.03%	437
2021 Q3	$7.41M	Sell	151,000 -26,600	-15%	-$1.3M	0.03%	445
2021 Q2	$7.41M	Buy	177,600 +18,900	+12%	+$733K	0.03%	444
2021 Q1	$5.66M	Buy	158,700 +52,200	+49%	+$1.73M	0.02%	478
2020 Q4	$2.99M	Buy	+106,500	New	+$2.97M	0.01%	591

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

STRS Ohio's MRVI Position: Q2 2026 in Review

STRS Ohio reduced its Maravai LifeSciences (MRVI) stake by 17% in Q2 2026, selling an estimated $123K and leaving 135,800 shares worth $847K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

STRS Ohio first reported a position in MRVI in Q4 2020 and has held it in 14 quarters since. The position peaked at $7.57M in Q4 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

STRS Ohio held 135,800 shares of Maravai LifeSciences worth $847K as of Q2 2026.
STRS Ohio sold 28,500 Maravai LifeSciences shares in Q2 2026, an estimated $123K.
Maravai LifeSciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #808 holding.
STRS Ohio first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 14 quarters since.
STRS Ohio's Maravai LifeSciences position peaked at $7.57M in Q4 2021.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.